Innovative Industrial Properties, Inc. (NYSE:IIPR) Files An 8-K Entry into a Material Definitive AgreementItem 1.01.Entry into a Material Definitive Agreement.
On November 21, 2017, Innovative Industrial Properties, Inc. (the "Company"), through its operating partnership subsidiary, IIP Operating Partnership, LP, entered into a definitive purchase and sale agreement (the "Purchase Agreement") with a subsidiary of The Pharm, LLC ("The Pharm") to acquire a property in Arizona comprised of approximately 358,000 square feet of greenhouse and industrial space (the "Property") in a sale-leaseback transaction. Concurrently with the closing of the acquisition of the Property, the Company expects to enter into a triple-net lease (the "Lease") with The Pharm subsidiary for the entire Property, the form of which is attached as an exhibit to the Purchase Agreement. The Pharm and its subsidiaries are state-licensed operators of medical-use cannabis cultivation, processing and dispensing facilities in the state of Arizona. The Pharm intends to continue to operate the Property as a medical-use cannabis cultivation and processing facility under the Lease.
The purchase price for the Property is $15.0 million (the "Purchase Price"). Under the Lease, the Company is expected to reimburse The Pharm for up to $3.0 million in tenant improvements at the Property (the "TI Allowance"). The Company intends to fund the Purchase Price and TI Allowance in cash using the remaining proceeds from its initial public offering completed in December 2016 and a portion of the proceeds from its offering of 9.0% Series A Cumulative Redeemable Preferred Stock completed in October 2017.
The initial Lease term is 15 years, with two options to extend the term for two additional five-year periods. The initial annualized base rent (the "Base Rent") under the Lease is $2,520,000, payable monthly, which is equal to 14% of the sum of the Purchase Price and TI Allowance, and subject to annual increases of 3.25% during the Lease term. The Base Rent on $5.0 million of the Purchase Price ($58,333.33 per month) will be abated until March 31, 2018, and the Base Rent attributable to the TI Allowance ($35,000 per month) will be abated until the earlier to occur of the drawdown of the TI Allowance by The Pharm subsidiary under the Lease and three months after commencement of the Lease term. The Lease will also provide that The Pharm subsidiary, as tenant, is responsible for paying all structural repairs, maintenance expenses, insurance and taxes related to the Property. The Pharm subsidiary is also responsible for paying the Company a property management fee equal to 1.5% of the then-existing Base Rent under the Lease.
to the Lease, The Pharm subsidiary is required to deliver to the Company an initial security deposit of $630,000 in cash upon execution of the Lease. In addition, any entity affiliated with The Pharm and operating in the cannabis industry in the state of Arizona, including any entity formed during the term of the Lease, shall enter into a full guaranty with respect to The Pharm subsidiary's obligations under the Lease, the form of which is attached as an exhibit to the Lease.
The Company's purchase of the Property is subject to the Company's ongoing diligence and the satisfaction of closing conditions as described in the Purchase Agreement. There can be no assurance that the Company will consummate the acquisition of the Property on the terms described herein, or at all.
The foregoing description of the Purchase Agreement is not complete and is subject to, and qualified in its entirety by, the full text of the Purchase Agreement, which is filed as an exhibit to this report and incorporated herein by reference. The Purchase Agreement contains representations and warranties made by the parties as of specific dates and solely for their benefit. The representations and warranties reflect negotiations between the parties and are not intended as statements of fact to be relied upon by the Company’s stockholders or any other person or entity other than the parties to the Purchase Agreement and, in certain cases, represent allocation decisions among the parties and may be subject to important qualifications and limitations agreed to by the parties in connection with the negotiation of the Purchase Agreement (which disclosures are not reflected in the Purchase Agreement itself, may not be true as of any date other than the date made, or may apply standards of materiality in a way that is different from what may be viewed as material by stockholders). Accordingly, the representations and warranties may not describe the actual state of affairs at the date they were made or at any other time, and stockholders should not rely on them as statements of fact. Moreover, information concerning the subject matter of the representations and warranties may change after the date of the Purchase Agreement.
Item 1.01 RegulationFD Disclosure.
On November 28, 2017, the Company issued a press release regarding the execution of the Purchase Agreement for the Property. A copy of the press release is attached hereto as Exhibit99.1. The information contained in Item 1.01 of this report, including Exhibit99.1, is being furnished and shall not be deemed “filed” for purposes of Section18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
Item 1.01 Financial Statements and Exhibits.
Forward-Looking Statements
This report contains statements that the Company believes to be “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than historical facts, including, without limitation, statements regarding the acquisition and lease of the Property, are forward looking statements. When used in this press release, words such as the Company “expects,” “intends,” “plans,” “estimates,” “anticipates,” “believes” or “should” or the negative thereof or similar terminology are generally intended to identify forward-looking statements. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, such statements. Investors should not place undue reliance upon forward-looking statements.
INNOVATIVE INDUSTRIAL PROPERTIES INC ExhibitEX-10.1 2 tv480307_ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 PURCHASE AND SALE AGREEMENT AND JOINT ESCROW INSTRUCTIONS FLYING DUTCHMAN REAL ESTATE HOLDINGS,…To view the full exhibit click here
About Innovative Industrial Properties, Inc. (NYSE:IIPR)
Innovative Industrial Properties, Inc. is focused on the acquisition, ownership and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. The Company intends to acquire its properties through sale-leaseback transactions and third-party purchases. It is focused on leasing its properties on a triple-net lease basis, where the tenant is responsible for all aspects of and costs related to the property and its operation during the lease term, including maintenance, taxes and insurance. The Company intends to conduct business in an umbrella partnership real estate investment trust (UPREIT), structure through its operating partnership. The Company’s real estate investments will consist of primarily properties suitable for cultivation and production of medical-use cannabis.